Hennrich, Patrick http://orcid.org/0000-0001-5924-047X
Arnold, Christine http://orcid.org/0000-0003-4201-1800
Koetsenruijter, Jan http://orcid.org/0000-0003-4632-5129
Wensing, Michel http://orcid.org/0000-0001-6569-8137
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (416396249, 416396249, 416396249, 416396249)
Universitätsklinikum Heidelberg
Article History
Received: 5 April 2022
Accepted: 28 September 2022
First Online: 18 October 2022
Declarations
:
: ExKoCare obtained ethics approval by the Ethikkommission der Medizinischen Fakultät Heidelberg [Ethics Committee of the medical faculty of Heidelberg] under ID S-726/2018. In Baden-Württemberg, an additional approval from the Landesärztekammer (state authorisation association for medical issues) was required and obtained for conducting the patient survey under ID B-F-2020–051. The study was performed in accordance with the Declaration of Helsinki. We obtained a signed declaration of informed consent from every patient participating in the qualitative study. Declarations of consent for patients in the quantitative study were waived by the Ethics Committee of the medical faculty of Heidelberg, since the study was anonymous. ExKoCare was registered at the German Clinical Trials Register (ExternalRef removed) on 07 Nov. 2019 under ID DRKS00019219.
: Not applicable.
: The authors declare that they have no competing interests.